Track the bioAffinity Technologies, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 14 January 2025 (Attribution). Among the most active insiders: GIRGENTI STEVEN. Every trade is accessible without an account.
62
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
64,848 shares@ US$1.16100.0% of flowCommon StockSEC:0001493152-24-015790:0
25 of 62 declarations
Acerca de bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. es una empresa centrada en el desarrollo de tecnologías de diagnóstico y tratamiento para el cáncer. Su objetivo es proporcionar soluciones innovadoras para mejorar los resultados de los pacientes.